[Clinical pharmacology of the most frequently used aminoglucosides: gentamycin, tobramycin and amikacin].
D000583:Amikacin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy / Q000378:metabolism; D004347:Drug Interactions; D004352:Drug Resistance, Microbial; D004423:Ear / Q000187:drug effects; D005839:Gentamicins / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D007668:Kidney / Q000187:drug effects; D014031:Tobramycin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*
D005839:Gentamicins; D007612:Kanamycin; D000583:Amikacin; D014031:Tobramycin
Farmacología clínica de los aminoglucósidos más utilizados: gentamicina, tobramicina y amikacina.